RhoVac recruits Steven Glazer as Medical Director
RhoVac AB (“RhoVac”) announced today, September 18, 2018, that the company has recruited Dr. Steven Glazer to the position of Medical Director (MD), commencing immediately.Steven Glazer has been recruited as Medical Director of RhoVac. Steven has extensive expertise and long-term international experience in both strategic and operational clinical development in the pharmaceutical and biotechnology industry in both the US and Europe. Steven's previous assignments include Senior Vice President Development at Bioinvent International AB, Director of Haematology at Novo Nordisk AS and Chief